GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CELLUMED Co Ltd (XKRX:049180) » Definitions » Gross Profit

CELLUMED Co (XKRX:049180) Gross Profit : ₩10,741 Mil (TTM As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is CELLUMED Co Gross Profit?

CELLUMED Co's gross profit for the three months ended in Sep. 2024 was ₩2,311 Mil. CELLUMED Co's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ₩10,741 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. CELLUMED Co's gross profit for the three months ended in Sep. 2024 was ₩2,311 Mil. CELLUMED Co's Revenue for the three months ended in Sep. 2024 was ₩33,283 Mil. Therefore, CELLUMED Co's Gross Margin % for the quarter that ended in Sep. 2024 was 6.94%.

CELLUMED Co had a gross margin of 6.94% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of CELLUMED Co was 39.55%. The lowest was 5.51%. And the median was 12.81%.


CELLUMED Co Gross Profit Historical Data

The historical data trend for CELLUMED Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CELLUMED Co Gross Profit Chart

CELLUMED Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,017.00 14,326.34 14,361.76 13,630.93 5,632.07

CELLUMED Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,230.69 3,385.56 3,295.68 1,748.91 2,311.24

Competitive Comparison of CELLUMED Co's Gross Profit

For the Medical Instruments & Supplies subindustry, CELLUMED Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CELLUMED Co's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CELLUMED Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where CELLUMED Co's Gross Profit falls into.



CELLUMED Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

CELLUMED Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=95552.96 - 89920.889
=5,632

CELLUMED Co's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=33283.137 - 30971.902
=2,311

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩10,741 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

CELLUMED Co's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2,311 / 33283.137
=6.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


CELLUMED Co  (XKRX:049180) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

CELLUMED Co had a gross margin of 6.94% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


CELLUMED Co Gross Profit Related Terms

Thank you for viewing the detailed overview of CELLUMED Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


CELLUMED Co Business Description

Traded in Other Exchanges
N/A
Address
Acetechno Tower 9 402, Gasan-dong, Geumcheon-gu, Seoul, KOR, 153-782
CELLUMED Co Ltd is a Korean company which is engaged in manufacturing and sale of medical equipment and biosimilars. Its products portfolio includes allografts for tissue repair, bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration and biosimilars such as bone morphogenetic protein 2 (BMP2) reagents and others. It also produces medical devices, such as spinal fixation systems, joint replacements, and navigation systems.

CELLUMED Co Headlines

No Headlines